Found 361 Results
Page 1 of 37

Direct Dirigeants

DIRECT DIRIGEANTS – EasyBourse A debate during which Onxeo’s CEO presents the company’s development strategy, activities, results and prospects.   […]


Onxeo Has Applied for Admission to Trading on Nasdaq First North Growth Market Denmark and Delisting from Nasdaq Main Market Copenhagen

Paris (France), November 27, 2020 – 6 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]


Analysts call following DRIIV-1b interim results

November 9, 2020 Access management presentation Access live webcast replay


Onxeo Announces Completion of Patient Enrollment in DRIIV-1b Study and Positive Interim Results

The last patient was treated with AsiDNA™ in combination with carboplatin and paclitaxel in this Phase 1b study in patients […]



AACR Annual Meeting 2021

  Discovery Science Driving Clinical Breakthroughs For more information…  


4th Annual PARP & DDR Inhibitors Summit

  For more information and to register…

H.C. Wainwright BioConnect 2021 Conference

More information coming soon …

Bryan Garnier & Co European Healthcare Conference

The annual European Healthcare Conference is one of the top events organized by Bryan, Garnier & Co. By invitation only, […]

Page 1 of 37

No more results